tobramycin has been researched along with loteprednol etabonate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bateman, KM; Comstock, TL; Macy, JI; White, EM | 1 |
| Bartlett, JD; Comstock, TL; Holland, EJ; Paterno, MR; Usner, DW | 2 |
| Comstock, TL; Holland, EJ | 1 |
| Conway, T; D'Aversa, G; Digby, D; Hollander, DA; Mah, F; Rajpal, RK | 1 |
| Chen, M; Gong, L; Gu, Y; He, X; Qu, J; Sun, X; Wang, L; Zhang, M; Zhong, X | 1 |
| Bateman, KM; Comstock, TL; Decory, HH; Gearinger, M; Paterno, MR | 1 |
| Amparo, F; Arnoldner, MA; Dana, R; Dohlman, TH; Hamrah, P; Jamali, A; Kheirkhah, A | 1 |
| Comstock, TL; DeCory, HH | 1 |
| Bunce, C; Dahlmann-Noor, A; Hingorani, M; Larkin, F; O'Gallagher, M; Tuft, S | 1 |
| Abraham, AG; Gregory, D; Hauswirth, S; Ifantides, C; Li, T; Liu, SH; Rittiphairoj, T; Saldanha, IJ | 1 |
3 review(s) available for tobramycin and loteprednol etabonate
| Article | Year |
|---|---|
Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens.
Topics: Administration, Topical; Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Drug Combinations; Eye Diseases; Humans; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Ophthalmic Solutions; Tobramycin | 2010 |
Topical treatments for blepharokeratoconjunctivitis in children.
Topics: Administration, Topical; Anti-Allergic Agents; Anti-Bacterial Agents; Blepharitis; Child; Child, Preschool; Conjunctiva; Eyelids; Humans; Infant; Infant, Newborn; Keratoconjunctivitis; Loteprednol Etabonate; Randomized Controlled Trials as Topic; Tobramycin | 2017 |
Topical corticosteroids for dry eye.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cataract; Child; Child, Preschool; Cyclosporine; Dry Eye Syndromes; Female; Glucocorticoids; Humans; Loteprednol Etabonate; Lubricant Eye Drops; Male; Randomized Controlled Trials as Topic; Tobramycin | 2022 |
7 trial(s) available for tobramycin and loteprednol etabonate
| Article | Year |
|---|---|
Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Blepharitis; Dexamethasone; Drug Combinations; Female; Humans; Intraocular Pressure; Keratoconjunctivitis; Loteprednol Etabonate; Male; Middle Aged; Tobramycin; Treatment Outcome; Visual Acuity | 2008 |
Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers.
Topics: Adolescent; Adult; Aged; Androstadienes; Anti-Bacterial Agents; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intraocular Pressure; Loteprednol Etabonate; Male; Microscopy, Acoustic; Middle Aged; Ophthalmic Solutions; Tobramycin; Tonometry, Ocular; Visual Acuity | 2008 |
Tolerability of loteprednol/tobramycin versus dexamethasone/tobramycin in healthy volunteers: results of a 4-week, randomized, double-masked, parallel-group study.
Topics: Adolescent; Adult; Aged; Androstadienes; Dexamethasone; Double-Blind Method; Female; Humans; Loteprednol Etabonate; Male; Middle Aged; Patient Compliance; Tobramycin | 2008 |
A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.
Topics: Adult; Androstadienes; Anti-Bacterial Agents; Asian People; Dexamethasone; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Keratoconjunctivitis; Loteprednol Etabonate; Male; Middle Aged; Tobramycin; Treatment Outcome | 2012 |
Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.
Topics: Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Child; Child, Preschool; Conjunctivitis; Double-Blind Method; Drug Eruptions; Eyelids; Female; Fever; Humans; Incidence; Infant; Infant, Newborn; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Male; Multicenter Studies as Topic; Ophthalmic Solutions; Safety; Tobramycin; Vision, Ocular; Visual Acuity | 2012 |
Effects of corneal nerve density on the response to treatment in dry eye disease.
Topics: Androstadienes; Anti-Allergic Agents; Anti-Bacterial Agents; Cornea; Double-Blind Method; Drug Therapy, Combination; Dry Eye Syndromes; Eyelid Diseases; Female; Humans; Loteprednol Etabonate; Lubricant Eye Drops; Male; Meibomian Glands; Microscopy, Confocal; Middle Aged; Ophthalmic Nerve; Ophthalmic Solutions; Prospective Studies; Surveys and Questionnaires; Tobramycin | 2015 |
Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Anti-Bacterial Agents; Asian People; Blepharitis; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Tobramycin; Treatment Outcome; Visual Acuity; Young Adult | 2017 |
2 other study(ies) available for tobramycin and loteprednol etabonate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
Topics: Adult; Aged; Androstadienes; Anti-Inflammatory Agents; Cohort Studies; Drug Combinations; Drug Monitoring; Eye Diseases; Female; Glucocorticoids; Humans; Intraocular Pressure; Loteprednol Etabonate; Male; Medical Records; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Retrospective Studies; Severity of Illness Index; Time Factors; Tobramycin | 2011 |